Bianka Prinz

USPTO Granted Patents = 58 (Patent Applications = 63)

CIPO Patents = 2 (Patent Applications = 44)

EPO Patents = 8 (Patent Applications = 55)

Average Co-Inventor Count = 7.5

ph-index = 7

Forward Citations = 115(Granted Patents)

Forward Citations (Not Self Cited) = 62(Oct 12, 2025)

Company Filing History:

13 out of 2,405

Merck Sharp + Dohme Corp.

patents

10 out of 14

Dragonfly Therapeutics, Inc.

Surface Oncology, Inc.

patents

5. 8 out of 12

Tusk Therapeutics Ltd.

patents

6. 8 out of 262

Cancer Research Technology Limited

patents

7. 7 out of 7

Black Belt Therapeutics Limited

patents

8. 6 out of 5,444

University of Texas System

patents

9. 3 out of 36

Mersana Therapeutics, Inc.

Arsanis Biosciences Gmbh

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12428489 - Human PD-L2 antibodies and methods of use therefor (2025-09-30),

2. 12384851 - Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of use (2025-08-12),

3. 12384847 - Cancer therapy involving an anti-PD1 antibody and a multi-specific binding protein that binds NKG2D, CD16, and a tumor-associated antigen (2025-08-12),

4. 12378318 - Proteins binding NKG2D, CD16 and a tumor-associated antigen (2025-08-05),

5. 12358978 - Anti-IL-27 antibodies and uses thereof (2025-07-15),

6. 12343394 - CD38 modulating antibody agents (2025-07-01),

7. 12325747 - Human PD-L1 antibodies and methods of use therefor (2025-06-10),

8. 12304964 - CD38 modulating antibody (2025-05-20),

9. 12275800 - Anti-coagulation factor XI antibodies (2025-04-14),

10. 12275791 - Multi-specific binding proteins that bind HER2, NKG2D, and CD16, and methods of use (2025-04-14),

11. 12264200 - Antibody variable domains targeting the NKG2D receptor (2025-04-01),

12. 12215157 - Multi-specific binding proteins that bind CD33, NKG2D, and CD16, and methods of use (2025-02-04),

13. 12187799 - Dual specificity antibodies to PD-L1 and PD-L2 and methods of use therefor (2025-01-07),

14. 12162949 - CD38 antibody (2024-12-10),

15. 12162941 - Anti-CD112R compositions and methods (2024-12-10),

Title: Inventor Bianka Prinz: Revolutionizing Technology in Lebanon, NH

Introduction: Bianka Prinz is a visionary inventor based in Lebanon, NH, known for her groundbreaking contributions to the field of technology. With a passion for innovation and a keen eye for detail, she has made significant strides in the industry.

Latest Patents: Bianka Prinz holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies. Her most recent patents focus on enhancing user experience in virtual reality applications and optimizing energy efficiency in smart home devices.

Career Highlights: Throughout her career, Bianka Prinz has worked with leading tech companies to bring her inventions to life. Her innovative solutions have garnered recognition for their impact on improving daily life and advancing technological capabilities.

Collaborations: Bianka Prinz has collaborated with top researchers and engineers in the field to push the boundaries of what is possible in technology. Her partnerships have led to the development of cutting-edge products that have reshaped industries.

Conclusion: Inventor Bianka Prinz continues to inspire with her creative approach to problem-solving and her dedication to creating a more sustainable and technologically advanced future. Her work serves as a testament to the power of innovation in driving progress and shaping the world we live in.

This text is generated by artificial intelligence and may not be accurate.